FeesSafety
Pluang+

Five-year data show Leqembi treatment increasingly benefits early Alzheimer's patients' cognition and daily function.

Company Fundamentals
17 Nov 2026, 05:17 WIB
PRNewsWire
View Source
Bullish
Five-year data show Leqembi treatment increasingly benefits early Alzheimer's patients' cognition and daily function.

New five-year data from the Clarity AD study reveal that continuous treatment with Leqembi significantly slows cognitive and functional decline in early Alzheimer's disease patients, especially those treated at an earlier stage with low tau levels. The study showed a 36% reduced risk of disease progression and 62% of early-stage patients improved in cognitive function after five years. Safety remained consistent with no new concerns, supporting early and sustained treatment. This reinforces Leqembi's role as a disease-modifying therapy targeting amyloid protofibrils and plaques, with ongoing global regulatory reviews and clinical trials.

The five-year data on continuous Leqembi treatment provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 17, 2026 10:02 WIB: out of 150 priced US health-sector stocks, 29 rose and 120 fell today. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 8.48 with a 1-day change of -11.76%, FLNA (Cassava Sciences Inc) at USD 0.47 with +10.56% and a Pluang order activity of 37% Sell / 63% Buy, and HRTX (Heron Therapeutics Inc) at USD 0.28 with -9.82% and balanced Pluang order activity.

More News

XP Inc. beats revenue estimates but misses EPS in Q3, announces share buyback and dividend.

XP Inc. beats revenue estimates but misses EPS in Q3, announces share buyback and dividend.

XP Inc. reported Q3 earnings with revenue of $989.8 million, surpassing expectations, but earnings per share of $0.52 fell short of estimates. The company saw an 8% increase in gross revenue year-over-year and a 4% rise in adjusted net income. XP als...

Company Fundamentals
Bullish
2 hours ago
Restaurant Capelin named Canada's best new restaurant of 2026 by Air Canada.

Restaurant Capelin named Canada's best new restaurant of 2026 by Air Canada.

Air Canada has named Restaurant Capelin in St. Catharines, Ontario, as the top new restaurant in Canada for 2026, recognizing its seafood-focused, seasonal menu and warm hospitality. The restaurant, opened in 2025 by Chef Alex Seaborn and Kat Seaborn...

Others
Neutral
2 hours ago
Air Canada names Capelin top new restaurant in Canada for 2026, celebrating 25 years of culinary excellence.

Air Canada names Capelin top new restaurant in Canada for 2026, celebrating 25 years of culinary excellence.

Air Canada has awarded the top spot in its 2026 Best New Restaurants list to Capelin, a seafood-focused restaurant in St. Catharines, Ontario, known for its seasonal local ingredients and warm hospitality. This recognition marks the 25th anniversary ...

Others
Neutral
2 hours ago
DTC launches MAGIC software to boost anti-jamming in tactical communications.

DTC launches MAGIC software to boost anti-jamming in tactical communications.

Domo Tactical Communications (DTC) introduced MAGIC, an advanced software technology designed to counteract electronic jamming in tactical communications. MAGIC enhances signal resilience by automatically suppressing interference without needing prio...

Others
Bullish
4 hours ago
Ziphius appoints vaccine veteran Antoon Loomans to board to boost strategic growth and funding.

Ziphius appoints vaccine veteran Antoon Loomans to board to boost strategic growth and funding.

Ziphius, a biotech firm specializing in self-amplifying RNA vaccines, has appointed Antoon Loomans to its board of directors to lead U.S. business development and strategic partnerships. Loomans brings 30 years of vaccine industry experience, includi...

Company Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App